急诊科COVID-19患者气管插管的现状与不良事件:多中心队列研究
本研究为前瞻性观察性多中心研究,纳入2020年4月至2023年3月在日本14家机构急诊科接受气管插管的1984例患者,分为COVID-19组(287例)和非COVID-19组(1697例)。COVID-19组首次插管成功率显著更高,但围插管不良事件发生率显著高于非COVID-19组(51.6% vs 17.1%,p<0.001),低氧血症是最常见的不良事件。多变量logistic回归显示COVID-19与不良事件风险升高独立相关(调整OR 1.69,95%CI 1.17-2.42,p=0.005)。作者结论认为COVID-19患者尽管插管成功,气道管理期间仍面临不成比例的高危并发症风险。
要点
- 急诊COVID-19患者围插管不良事件发生率为51.6%,显著高于非COVID-19组的17.1%(p<0.001)。
- 低氧血症是COVID-19组最常见的不良事件。
- 多变量回归显示COVID-19与插管不良事件风险升高独立相关(调整OR 1.69,95%CI 1.17-2.42,p=0.005)。
- COVID-19组首次插管成功率显著高于非COVID-19组。
- 主要不良事件定义为心脏骤停、低血压、低氧血症和心律失常。
适用人群与场景
- 2020年4月至2023年3月在日本14家机构急诊科接受气管插管的患者,共1984例,其中COVID-19组287例,非COVID-19组1697例。
研究设计与关键结果
- 研究类型为前瞻性观察性多中心研究,纳入14家机构急诊科1984例气管插管患者,COVID-19组287例,非COVID-19组1697例。
- COVID-19组首次插管成功率显著高于非COVID-19组。
- 围插管不良事件发生率COVID-19组51.6% vs 非COVID-19组17.1%(p<0.001),低氧血症为最常见不良事件。
- 多变量logistic回归显示COVID-19组不良事件风险升高(调整OR 1.69,95%CI 1.17-2.42,p=0.005)。
- 主要不良事件定义为心脏骤停、低血压、低氧血症和心律失常。
证据类型、等级与局限
- 证据类型:前瞻性观察性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,COVID-19患者尽管插管成功,气道管理期间仍面临不成比例的高危并发症风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: During the COVID-19 pandemic, the demand for tracheal intubations increased in emergency departmeants (EDs). We aimed to describe tracheal intubations during the COVID-19 pandemic in Japan and investigate the association between COVID-19 and intubation-related adverse events in EDs.
METHODS: This is an analysis of a prospective observational multicenter study involving patients who underwent tracheal intubations in the ED between April 2020 and March 2023. Patients were divided into two groups: the COVID-19 group and the non-COVID-19 group. To examine the association between COVID-19 and the risk for adverse events during tracheal intubation, a multivariable logistic regression analysis was performed. Major adverse events were defined as cardiac arrest, hypotension, hypoxemia, and dysrhythmia.
RESULTS: At 14 institutions, 1984 patients underwent tracheal intubations in the ED (287 in the COVID-19 group and 1697 patients in the non-COVID-19 group). Despite a significantly higher rate of first-attempt intubation success in the COVID-19 group, the incidence of peri-intubation adverse events was significantly elevated compared to the non-COVID-19 group (51.6 % vs. 17.1 %; p < 0.001). Hypoxemia was the most common adverse event. Multivariable regression analysis revealed that the COVID-19 group was significantly associated with a higher risk of adverse events (adjusted odds ratio, 1.69; 95 % confidence interval, 1.17-2.42; p = 0.005).
CONCLUSIONS: Patients with COVID-19, though undergoing successfully intubations, remained at disproportionately higher risk for critical complications during airway management.
参考来源
- Miwa M, Nakajima M, Kaszynski RH, et al. Current status and adverse events of tracheal intubation for patients with COVID-19 in emergency department: A multicenter cohort study. Am J Emerg Med. 2025. PMID: 40516224. doi:10.1016/j.ajem.2025.06.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。